Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
10/2002
10/10/2002CA2435828A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
10/10/2002CA2434677A1 Molecules for diagnostics and therapeutics
10/10/2002CA2431938A1 A novel vaccine formulation consisting of dna vaccine inactivated virus
10/10/2002CA2430684A1 Micromonospora echinospora genes encoding for biosynthesis of calicheamicin and self-resistance thereto
10/10/2002CA2429265A1 Mammalian alpha-helical protein-53
10/09/2002EP1247867A1 Gene encoding plant resistance protein to the tomato mosaic tobamovirus (ToMV)
10/09/2002EP1247864A2 58297, an amino acid transporter and uses therefor
10/09/2002EP1247863A1 Polypeptide and nucleic acid encoding the same
10/09/2002EP1247862A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247861A1 Method of examining vulgar psoriasis
10/09/2002EP1247817A2 Human CD23-like protein and nucleic acids encoding it
10/09/2002EP1247816A1 Immunogen, antivenom and vaccine against the venom of the black widow spider
10/09/2002EP1247531A2 TNF-derived peptides for use in treating oedema
10/09/2002EP1247530A2 Keratinocyte growth factor-2 (KGF-2 or fibroblast growth factor-12, FGF-12)
10/09/2002EP1247103A2 Tethered ligands and methods of use
10/09/2002EP1247100A1 Interaction between cd14 and hbv components
10/09/2002EP1247099A2 Methods and compositions for detecting hepatitis e virus
10/09/2002EP1247095A2 High affinity tcr proteins and methods
10/09/2002EP1247094A2 ASSAYS FOR DETECTION OF i BACILLUS ANTHRACIS /i
10/09/2002EP1246944A1 PCR-BASED DETECTION OF i RHIZOCTONIA CEREALIS /i
10/09/2002EP1246933A1 Method for making insulin precursors and insulin precursor analogues having improved fermentation yield in yeast
10/09/2002EP1246926A2 Methods of identifying modulators of the fgf receptor
10/09/2002EP1246925A1 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/09/2002EP1246923A2 Dna modification proteins
10/09/2002EP1246921A2 Increased lysine production by gene amplification using coryneform bacteria
10/09/2002EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002EP1246919A1 Progenitor cell preservation factors and related methods and products
10/09/2002EP1246918A2 Secreted proteins
10/09/2002EP1246917A2 Human stra6 polypeptides
10/09/2002EP1246916A2 26904, 38911, and 39404, seven-transmembrane proteins / g-protein coupled receptors
10/09/2002EP1246914A2 Nope polypeptides, encoding nucleic acids and methods of use
10/09/2002EP1246910A1 T cell receptor libraries
10/09/2002EP1246901A1 Methods for protein transfer
10/09/2002EP1246847A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
10/09/2002EP1246846A2 Soluble interleukin-20 receptor
10/09/2002EP1246845A1 Method for making insulin precursors and insulin precursor analogs
10/09/2002EP1246844A1 Interleukin-1 receptor antagonist-related molecules and uses thereof
10/09/2002EP1246843A1 Novel fgf homolog zfgf12
10/09/2002EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002EP1246841A1 Transcription factors containing two potential dna binding motifs
10/09/2002EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002EP1246837A2 Oligomers of nonpeptide restricted mimetics of dipeptides or tripeptides and the use thereof in the synthesis of synthetic proteins and polypeptides
10/09/2002EP1246834A1 Epididymal antimicrobial peptides
10/09/2002EP1246647A1 Non-immunosuppressant hiv tat
10/09/2002EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/09/2002EP1246644A1 Inducing cellular immune responses to human papillomavirus using peptide and nucleic acid compositions
10/09/2002EP1246643A2 Dna vaccines encoding antigen linked to a domain that binds cd40
10/09/2002EP1246638A1 Use of exendins and agonists thereof for modulation of triglyceride levels and treatment of dyslipidemia
10/09/2002EP1246637A2 Methods of modulation of the immune system
10/09/2002EP1246616A1 Cell permeable peptides for inhibition of inflammatory reactions and methods of use
10/09/2002EP1246597A2 Polypeptides and polynucleotides for enhancing immune reactivity to her-2 protein
10/09/2002EP1194445A4 Methods for protein purification using aqueous two-phase extraction
10/09/2002EP1180160A4 Antibiotic-based gene regulation system
10/09/2002EP1105731A4 Profiling and cataloging expressed protein tags
10/09/2002EP0979277A4 Novel human tumour suppressor gene
10/09/2002EP0960336B1 Peptide reagent for the detection of human cytomegalovirus (cmv)
10/09/2002EP0838473B1 Peptide for inhibiting blood triglyceride level rise and inhibitor for blood triglyceride level rise comprising the peptide as active ingredient
10/09/2002EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002EP0804562B1 Connective tissue growth factor-2
10/09/2002EP0783521B1 Polypeptide compounds containing d-2-alkyltryptophan capable of promoting the release of growth hormone
10/09/2002EP0743982B1 Immortalized human fetal osteoblastic cells
10/09/2002EP0732933B1 Use of igf-1 and igfbp-3 in the manufacture of a medicament for treating a renal disorder
10/09/2002EP0651761B1 Method for modification of recombinant polypeptides
10/09/2002EP0640098B1 Canine coronavirus s gene and uses therefor
10/09/2002CN1373807A Mosaic infections bursal disease virus vaccines
10/09/2002CN1373805A Antigenic meningococcal peptides
10/09/2002CN1373804A Conditional immortalisation of cells
10/09/2002CN1373799A Method for producing heterologous secreted protein from Chinese hamster ovary cells grown on microcarriers
10/09/2002CN1373774A Compositions isolated from skin cells and methods for their use
10/09/2002CN1373773A Polynucleotides encoding human angiotensin-II-1 receptor proteins and method of preparation and its use
10/09/2002CN1373772A Gene encoding human huntingtin interacting polypeptide which comprises WW domain and its producing method and application
10/09/2002CN1373771A Vaccine
10/09/2002CN1373669A Hybrid polypeptides with enhanced pharmacokinetic properties
10/09/2002CN1373668A Hybrid peptide modulate immune response
10/09/2002CN1373220A Coding sequence of human tonB-dependent receptor protein and its preparing process and application
10/09/2002CN1373219A Genetic engineering for recombining scorpion venom rBmKaIT1
10/09/2002CN1373218A Inflammatory suppressor factor Fwa 116
10/09/2002CN1373217A Cell multiplication factor Fwap10576
10/09/2002CN1373216A Muscle cell multiplication suppressor factor Fwa267
10/09/2002CN1373141A Gene recombinant fibroblast growth factor-8a polypeptide and method for preparing same
10/09/2002CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/08/2002US6462256 Nucleic acid molecules from wheat, transgenic plant cells and plants and the thereof for the production of modified starch
10/08/2002US6462255 Viral amplification of recombinant messenger RNA in transgenic plants
10/08/2002US6462254 Detecting gene expression of fusion proteins
10/08/2002US6462189 Fibronectins; monobody loop region varies with wild-type by deletions; binds to specific binding partner
10/08/2002US6462188 Drug screening for antiemetic and antipsychotic agents
10/08/2002US6462181 Process for preparing a kappa-caseino glycomacropeptide or a derivative thereof
10/08/2002US6462180 Precipitation; passing eluted solution through anionic and cationic exchange resins
10/08/2002US6462178 G protein
10/08/2002US6462177 Mammalian blood loss-induced gene, kd312
10/08/2002US6462176 Apo-3 polypeptide
10/08/2002US6462173 Inhibitors of phosphoserine and phosphothreonine-proline-specific isomerases
10/08/2002US6462172 Purification of tissue plasminogen activator (TPA)
10/08/2002US6462171 Inhibitory peptide for alzheimer*s and prion encephalopathy disease treatment
10/08/2002US6462170 UPAR mimicking peptide
10/08/2002US6462018 Fibrin polymer structure
10/08/2002US6462016 Method for screening agonist or antagonist of the maxadilan receptor participating in vasodilating action, and compound found by the method
10/08/2002US6461867 Synthetic antigen presenting matrix
10/08/2002US6461855 Microtubule stimulated atpase activity; cancer and nervous system disorder diagnosis
10/08/2002US6461854 Methods of screening compounds useful for prevention of infection or pathogenicity